Cencora Announces Common Share Repurchase From Walgreens Boots Alliance

8/1/24 6:17:00 PM ET

Other Pharmaceuticals

Health Care

Get the next $COR alert in real time by email

Cencora, Inc. (NYSE:COR) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount of approximately $250 million in concurrence with Walgreens Boots Alliance's sale of Cencora shares pursuant to Rule 144 under the Securities Act of 1933, as amended.

Cencora intends to repurchase shares from Walgreens Boots Alliance at the price per share equal to the price in the Rule 144 sale. The concurrent share repurchase will be made under Cencora's share repurchase program and the repurchased shares will be held in treasury.

About Cencora

Cencora is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. We partner with pharmaceutical innovators across the value chain to facilitate and optimize market access to therapies. Care providers depend on us for the secure, reliable delivery of pharmaceuticals, healthcare products, and solutions. Our 46,000+ worldwide team members contribute to positive health outcomes through the power of our purpose: We are united in our responsibility to create healthier futures. Cencora is ranked #10 on the Fortune 500 and #24 on the Global Fortune 500 with more than $250 billion in annual revenue.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240801321448/en/

Get the next $COR alert in real time by email

Recent Analyst Ratings for

$COR

Date	Price Target	Rating	Analyst
9/18/2024	$275.00 → $245.00	Buy → Neutral	BofA Securities
2/26/2024	$261.00	Outperform	Leerink Partners
1/3/2024	$242.00	Overweight	Barclays
12/14/2023	$213.00	Equal Weight	Wells Fargo
12/14/2021	$162.00 → $170.00	Buy → Neutral	Citigroup
11/26/2021	$136.00 → $170.00	Sector Perform	RBC Capital
11/16/2021		Underweight → Equal-Weight	Barclays
11/16/2021	$158.00 → $170.00	Outperform → Neutral	Credit Suisse

More analyst ratings

Cencora Announces Common Share Repurchase From Walgreens Boots Alliance

Chat with this insight

Recent Analyst Ratings for $COR

$COR Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Durcan Dermot Mark bought $109,290 worth of shares (500 units at $218.58), increasing direct ownership by 2% to 21,876 units (SEC Form 4)

$COR Press Releases

Fastest customizable press release news feed in the world

Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results

Cencora Advances Specialty Leadership Through Acquisition of Retina Consultants of America

Cencora Expands Enterprise Leadership Team with Two Senior Appointments

$COR Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Cencora downgraded by BofA Securities with a new price target

Leerink Partners initiated coverage on Cencora with a new price target

Barclays initiated coverage on Cencora with a new price target

$COR Financials

Live finance-specific insights

$COR Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

$COR Large Ownership Changes

This live feed shows all institutional transactions in real time.

$COR Market Insights

Live Market Insights

$COR SEC Filings

$COR Leadership Updates

Live Leadership Updates

Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results

Cencora Announces Date and Time for Fourth Quarter Fiscal 2024 Earnings Release

Cencora Reports Fiscal 2024 Third Quarter Results

Executive Chairman Collis Steven H exercised 21,509 shares at a strike of $89.58 and sold $5,208,619 worth of shares (21,509 units at $242.16) (SEC Form 4)

Executive Vice President Battaglia Silvana converted options into 5,319 shares and covered exercise/tax liability with 2,318 shares, increasing direct ownership by 27% to 13,949 units (SEC Form 4)

Executive Vice President Campbell Elizabeth S converted options into 5,126 shares and covered exercise/tax liability with 1,775 shares, increasing direct ownership by 40% to 11,655 units (SEC Form 4)

Amendment: SEC Form SC 13G/A filed by Cencora Inc.

Amendment: SEC Form SC 13D/A filed by Cencora Inc.

SEC Form SC 13G/A filed by CoreSite Realty Corporation (Amendment)

If You Invested $100 In This Stock 5 Years Ago, You Would Have $300 Today

AbbVie Appeals To Supreme Court Over Attorney-Client Privilege In 'Long-Standing' AndroGel Case

If You Invested $100 In This Stock 5 Years Ago, You Would Have $200 Today

Cencora Inc. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits

Cencora Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

Cencora Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

Cencora Expands Enterprise Leadership Team with Two Senior Appointments

Network Wireless Solutions (NWS) Appoints Michael Millegan to Board of Directors

Recent Analyst Ratings for
$COR

$COR
Insider Purchases

$COR
Press Releases

$COR
Analyst Ratings

$COR
Financials

$COR
Insider Trading

$COR
Large Ownership Changes

$COR
Market Insights

$COR
SEC Filings

$COR
Leadership Updates